Mitra Biotech’s CANscript™ is an ex-vivo translational platform that delivers powerful, individualized treatment response predictions — with exceptionally high correlation to clinical outcomes — to support more effective and efficient oncology drug development decision making and to inform patient-specific cancer therapeutic selection.

Eurofins DiscoverX, headquartered in Fremont, CA, USA, is a leader in the design and manufacture of biochemical and cell-based assays for the drug development and life science markets. This industry-leading portfolio of products, help to accelerate development of biologic and small molecule drugs, from discovery to QC lot release.